Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127126632 | 12712663 | 2 | F | 20160905 | 20160902 | 20160912 | EXP | IN-ABBVIE-16P-078-1717954-00 | ABBVIE | DIVECHA C, TULLU M, GANDHI A, DESHMUKH C. ACUTE INTERMITTENT PORPHYRIA: A CRITICAL DIAGNOSIS FOR FAVORABLE OUTCOME. INDIAN J CRIT CARE MED.. 2016 JUL;20(7):428-31. | 5.00 | YR | F | Y | 0.00000 | 20160912 | OT | COUNTRY NOT SPECIFIED | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127126632 | 12712663 | 1 | PS | VALPROATE SODIUM. | VALPROATE SODIUM | 1 | Unknown | FEW DAY (S) | UNKNOWN | 18081 | |||||||||
| 127126632 | 12712663 | 2 | SS | VALPROATE SODIUM. | VALPROATE SODIUM | 1 | UNKNOWN | 18081 | |||||||||||
| 127126632 | 12712663 | 3 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Other | UNKNOWN | 0 | ||||||||||
| 127126632 | 12712663 | 4 | SS | PHENYTOIN. | PHENYTOIN | 1 | Other | UNKNOWN | 0 | ||||||||||
| 127126632 | 12712663 | 5 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 127126632 | 12712663 | 6 | SS | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | FEW DAY (S) | UNKNOWN | 0 | |||||||||
| 127126632 | 12712663 | 7 | C | ACICLOVIR | ACYCLOVIR | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127126632 | 12712663 | 1 | Generalised tonic-clonic seizure |
| 127126632 | 12712663 | 2 | Somnolence |
| 127126632 | 12712663 | 3 | Steroid therapy |
| 127126632 | 12712663 | 4 | Product used for unknown indication |
| 127126632 | 12712663 | 5 | Product used for unknown indication |
| 127126632 | 12712663 | 6 | Hypertension |
| 127126632 | 12712663 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127126632 | 12712663 | HO |
| 127126632 | 12712663 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127126632 | 12712663 | Areflexia | |
| 127126632 | 12712663 | Chromaturia | |
| 127126632 | 12712663 | Condition aggravated | |
| 127126632 | 12712663 | Dyspnoea | |
| 127126632 | 12712663 | Generalised tonic-clonic seizure | |
| 127126632 | 12712663 | Hypertension | |
| 127126632 | 12712663 | Hyponatraemia | |
| 127126632 | 12712663 | Porphyria acute | |
| 127126632 | 12712663 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |